NOT-AG-20-027: Notice of NIA Participation in PAR-20-157 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)"

Notice of NIA Participation in PAR-20-157 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)"

Notice Number: NOT-AG-20-027

Key Dates
Release Date: April 10, 2020

Related Announcements
PAR-20-157 - Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants that the National Institute on Aging (NIA) is participating, effective immediately, in PAR-20-157 "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)".

The following text has been added to reflect NIA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Aging (NIA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.866

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Suzana Petanceska, PhD
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: [email protected]